Patent · US Expired

Trisubstituted triazines

US5238936A · kind A · utility

19Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 6, 1992
Grant dateAug 24, 1993
Priority date
Expiry dateMar 6, 2012

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The compounds are trisubstituted triazines and pyrimidines useful for the suppressing the resistance of tumour cells to anti-cancer agents and for suppressing the resistance of parasites to anti-parasitic agents. A compound disclosed is 2,4-diallylamino-6-{4-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl) methylamino]piperidin-1-yl}-1,3,5-triazine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.